
Orca-T Is Associated With Retrospective OS Improvement vs Post-Transplant Cyclophosphamide in Advanced Hematologic ...
Findings from a retrospective analysis revealed that the allogeneic T-cell immunotherapy Orca-T was associated with an improvement in overall survival (OS) compared with post-transplant cyclophosphamide in patients with advanced hematologic malignancies. …